• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 3. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 4. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 5. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960

Comprehensive Overview of 2-amino-2-(oxan-3-yl)acetic acid hydrochloride (CAS No. 1909305-59-4)

2-amino-2-(oxan-3-yl)acetic acid hydrochloride (CAS No. 1909305-59-4) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its unique oxan-3-yl moiety and amino acid backbone, serves as a critical intermediate in the synthesis of novel therapeutic agents. Its molecular structure combines a tetrahydro-2H-pyran ring with an amino acetic acid group, making it a versatile building block for drug discovery.

The growing interest in 2-amino-2-(oxan-3-yl)acetic acid hydrochloride is driven by its potential applications in peptide synthesis and medicinal chemistry. Researchers are particularly intrigued by its ability to modulate biological pathways, which aligns with current trends in targeted drug delivery and precision medicine. As the demand for custom synthesis and high-purity intermediates rises, this compound has become a focal point for laboratories specializing in small molecule development.

From a chemical perspective, 2-amino-2-(oxan-3-yl)acetic acid hydrochloride exhibits notable stability under standard laboratory conditions, making it suitable for various organic reactions. Its hydrochloride salt form enhances solubility in aqueous solutions, a property highly valued in pharmaceutical formulations. Recent studies have explored its role in creating bioactive scaffolds, particularly in the development of CNS-targeting compounds, a hot topic in neurology research.

The synthesis of 2-amino-2-(oxan-3-yl)acetic acid hydrochloride typically involves stereoselective methods to ensure high enantiomeric purity, a crucial factor for drug efficacy. This aligns with the pharmaceutical industry's emphasis on chiral intermediates, as evidenced by increasing Google searches for "chiral building blocks for drug discovery" and "pharmaceutical intermediates with high optical purity". The compound's oxan-3-yl group contributes to improved metabolic stability, addressing a common challenge in prodrug design.

In the context of market dynamics, the global demand for specialty chemical intermediates like 2-amino-2-(oxan-3-yl)acetic acid hydrochloride continues to grow, particularly in regions with strong biotech innovation ecosystems. Analytical techniques such as HPLC and NMR are routinely employed to verify its purity, reflecting industry standards for quality control in chemical synthesis. These aspects resonate with frequent search queries about "analytical methods for pharmaceutical intermediates" and "quality standards for research chemicals".

Looking ahead, 2-amino-2-(oxan-3-yl)acetic acid hydrochloride presents exciting opportunities in structure-activity relationship studies. Its molecular framework allows for diverse modifications, making it valuable for exploring new chemical entities in drug development pipelines. This aligns perfectly with current research priorities in fragment-based drug design and lead optimization, topics frequently discussed in recent scientific literature and online forums.

For researchers sourcing this compound, understanding its storage conditions and handling requirements is essential. Proper documentation of safety data and regulatory compliance information ensures responsible use in laboratory settings. These practical considerations address common user concerns visible in search trends, including "handling protocols for amino acid derivatives" and "stability of hydrochloride salts in research".

The unique combination of structural features in 2-amino-2-(oxan-3-yl)acetic acid hydrochloride positions it as a compound of continuing scientific interest. As research into heterocyclic compounds and amino acid analogs advances, this molecule's role in facilitating breakthroughs across multiple therapeutic areas appears increasingly promising. Its relevance to current investigations in neuropharmacology and enzyme inhibition makes it a noteworthy subject for ongoing scientific exploration.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)